Search research articles
Contact Us
Filters
Showing results (61-70 of 194) with videos related to
Page
of 20
Sort By:
Pharmaceutical Research
|
June 1, 1990
Influence of absorption rate, dosing frequency, and intrinsic pharmacokinetic profile on steady-state drug concentrations
M A Eldon, W A Colburn
Journal of Clinical Pharmacology
|
April 1, 1986
Controversy I: Patients or healthy volunteers for pharmacokinetic studies?
R K Brazzell, W A Colburn
Journal of Clinical Pharmacology
|
September 1, 1996
Efficacy measures: surrogates or clinical outcomes?
J W Blue, W A Colburn
Journal of Pharmacokinetics and Biopharmaceutics
|
October 1, 1975
RIV vs. CPB for prednisolone
W A Colburn, R H Buller
Journal of the American Academy of Dermatology
|
April 1, 1982
Pharmacokinetics of the retinoids isotretinoin and etretinate. A comparative review
R K Brazzell, W A Colburn
Biopharmaceutics & Drug Disposition
|
September 1, 1988
Noncompartmental area under the curve determinations for drugs that cycle in the bile
W A Colburn, R W Lucek
Clinical Pharmacokinetics
|
January 1, 1985
Clinical pharmacokinetics of the retinoids
R W Lucek, W A Colburn
Clinical Pharmacokinetics
|
September 1, 1987
Relationships between CSF drug concentrations, receptor binding characteristics, and pharmacokinetic and pharmacodynamic properties of selected 1,4-substituted benzodiazepines
W A Colburn, M L Jack
Steroids
|
November 1, 1973
Radioimmunoassay for methylprednisolone (Medrol)
W A Colburn, R H Buller
Journal of Pharmacokinetics and Biopharmaceutics
|
December 1, 1976
Pharmacokinetic analysis of drug concentration data obtained during repetitive drug administration
W A Colburn, D Shen, M Gibaldi
Page
of 20
Search research articles
Search
Showing results (61-70 of 194) with videos related to
Sort By:
Page
of 20
Pharmaceutical Research
|
June 1, 1990
Influence of absorption rate, dosing frequency, and intrinsic pharmacokinetic profile on steady-state drug concentrations
M A Eldon, W A Colburn
Journal of Clinical Pharmacology
|
April 1, 1986
Controversy I: Patients or healthy volunteers for pharmacokinetic studies?
R K Brazzell, W A Colburn
Journal of Clinical Pharmacology
|
September 1, 1996
Efficacy measures: surrogates or clinical outcomes?
J W Blue, W A Colburn
Journal of Pharmacokinetics and Biopharmaceutics
|
October 1, 1975
RIV vs. CPB for prednisolone
W A Colburn, R H Buller
Journal of the American Academy of Dermatology
|
April 1, 1982
Pharmacokinetics of the retinoids isotretinoin and etretinate. A comparative review
R K Brazzell, W A Colburn
Biopharmaceutics & Drug Disposition
|
September 1, 1988
Noncompartmental area under the curve determinations for drugs that cycle in the bile
W A Colburn, R W Lucek
Clinical Pharmacokinetics
|
January 1, 1985
Clinical pharmacokinetics of the retinoids
R W Lucek, W A Colburn
Clinical Pharmacokinetics
|
September 1, 1987
Relationships between CSF drug concentrations, receptor binding characteristics, and pharmacokinetic and pharmacodynamic properties of selected 1,4-substituted benzodiazepines
W A Colburn, M L Jack
Steroids
|
November 1, 1973
Radioimmunoassay for methylprednisolone (Medrol)
W A Colburn, R H Buller
Journal of Pharmacokinetics and Biopharmaceutics
|
December 1, 1976
Pharmacokinetic analysis of drug concentration data obtained during repetitive drug administration
W A Colburn, D Shen, M Gibaldi
Page
of 20